BlackRock Innovation and Growth Term Trust - Current Ratio

The Current Ratio as of August 2026 (TTM) for BlackRock Innovation and Growth Term Trust (BTX) is 0.13

According to BlackRock Innovation and Growth Term Trust’s latest financial reports and current stock price. The company's current Current Ratio is 0.13. This represents a change of -27.72% compared to the average of 0.18 of the last 4 quarters.

BlackRock Innovation and Growth Term Trust (BTX) Historical Current Ratio (quarterly & annually)

How has BTX Current Ratio performed in the past?

The mean historical Current Ratio of BlackRock Innovation and Growth Term Trust over the last ten years is 0.03. The current 0.13 Current Ratio has changed 49.90% with respect to the historical average. Over the past ten years (40 quarters), BTX's Current Ratio was at its highest in in the June 2025 quarter at 0.60. The Current Ratio was at its lowest in in the June 2021 quarter at 0.

BlackRock Innovation and Growth Term Trust (BTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BlackRock Innovation and Growth Term Trust Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BlackRock Innovation and Growth Term Trust (BTX) Average Current Ratio

How has BTX Current Ratio performed in the past?

The current Current Ratio of BlackRock Innovation and Growth Term Trust (BTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BlackRock Innovation and Growth Term Trust (BTX) Current Ratio vs. Peers

How is BTX’s Current Ratio compared to its peers?

BlackRock Innovation and Growth Term Trust’s Current Ratio is less than Theravance Biopharma Inc (13.14), less than Prime Medicine, Inc. (3.80), less than Tyra Biosciences, Inc. (14.91), less than Maravai LifeSciences Holdings, Inc. (5.91), less than Rezolute, Inc. (15.84), less than LENZ Therapeutics, Inc. (10.40), less than Kura Oncology, Inc. (6.15), less than Savara Inc. (13.47), less than GH Research PLC (23.04), less than CorMedix Inc. (2.98),

Build a custom stock screener for BlackRock Innovation and Growth Term Trust (BTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BlackRock Innovation and Growth Term Trust using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BlackRock Innovation and Growth Term Trust (BTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BlackRock Innovation and Growth Term Trust or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.